Q3 total revenue of $20.9M, compared to $17.7M in Q3 2018.
Received 8 new orders for MRIdian systems, totaling ~$35M.
Total backlog grew to ~$231M as of September 30, 2019.
Cash and equivalents were ~$92M as of September 30.
The Company reaffirmed its FY 2019 guidance of revenue in the range of $80M – 95M, and cash use in the range of $80M – 90M.
The company will hold a conference call on November 12, 2019 at 4:30 p.m. ET / 1:30 p.m. PT to discuss results.
https://seekingalpha.com/news/3505743-viewray-plus-13-percent-premarket-preliminary-q3-results
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.